A detailed history of Pictet Asset Management Sa transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 429,428 shares of KRYS stock, worth $76.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
429,428
Previous 632,393 32.09%
Holding current value
$76.2 Million
Previous $50.6 Million 0.42%
% of portfolio
0.06%
Previous 0.06%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$78.48 - $130.32 $15.9 Million - $26.5 Million
-202,965 Reduced 32.09%
429,428 $50.4 Million
Q1 2023

May 10, 2023

BUY
$72.39 - $84.27 $464,309 - $540,507
6,414 Added 1.02%
632,393 $50.6 Million
Q4 2022

Feb 13, 2023

SELL
$63.14 - $79.9 $6.2 Million - $7.85 Million
-98,223 Reduced 13.56%
625,979 $49.6 Million
Q3 2022

Nov 14, 2022

SELL
$64.85 - $82.4 $1.36 Million - $1.72 Million
-20,904 Reduced 2.81%
724,202 $50.5 Million
Q2 2022

Aug 09, 2022

BUY
$48.93 - $73.47 $2.77 Million - $4.15 Million
56,551 Added 8.21%
745,106 $48.9 Million
Q1 2022

May 13, 2022

SELL
$51.99 - $72.11 $667,967 - $926,469
-12,848 Reduced 1.83%
688,555 $45.8 Million
Q4 2021

Feb 10, 2022

BUY
$39.81 - $88.24 $2.54 Million - $5.64 Million
63,911 Added 10.03%
701,403 $49.1 Million
Q3 2021

Nov 12, 2021

BUY
$52.01 - $71.77 $33.2 Million - $45.8 Million
637,492 New
637,492 $33.3 Million

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.55B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.